HISTORY OF PRESENT ILLNESS:  A 45-year-old male with a history of asthma/COPD, last pulmonary function tests in [**2135-10-7**] showing a FVC of 2.5 (63%), FEV equals 0.47 on [**2135-12-27**], and recently treated as an outpatient for a congestive obstructive pulmonary disease exacerbation with a steroid taper until [**2136-1-7**], and Levaquin until [**2136-1-5**], presented to the Emergency Department with complaints of increased shortness of breath not relieved by inhalers, as well as productive-yellow cough.
He was noted to have excessive accessory muscle use, was given ceftriaxone and azithromycin.
Congestive obstructive pulmonary disease; on home oxygen six months ago.
Albuterol two puffs qid.
Bactrim double strength one tablet [**Hospital1 **].
Flovent 220 mcg six puffs [**Hospital1 **].
Prednisone taper.
Zyban 150 mg po bid.
Briefly supported with pressors requiring 10 liters of normal saline and Neo-Synephrine and Levophed support.
Initial respiratory acidosis trouble shot on assist-control ventilation.
Maintained on steroids and IV levofloxacin 500 mg q day with improvement with respiratory status and pneumonia.
Pulmonary arterial pressures, however, could not be determined given technical limitations to this study.
The patient continued to do well, and was extubated on [**1-13**], and transferred to the floor with stable respiratory status on 3 liters of supplemental nasal cannula oxygen.
Medicine [**Hospital1 **] course by problems: Pulmonary:  Pneumonia, bibasilar, continued to improve on po levofloxacin.
Regarding congestive obstructive pulmonary disease flare, patient was initially treated with standing albuterol and Atrovent nebulizers, used subsequently weaned to his usual outpatient MDI doses.
Continued a prednisone taper that was started in the MICU.
Continued to improve and required no supplemental oxygenation at rest by date of discharge.
Tobacco abuse:  The patient was continued on bupropion at 150 mg po q day.
He should be discharged from rehabilitation with a goal of using a nicotine patch in addition to the bupropion.
Endocrine:  The patient received cyanocobalamin supplementation throughout his course.
Patient was also started on calcium carbonate at 1,000 mg po bid to prophylax against bone loss given pernicity of steroid use.
Using Fosamax as an outpatient was discussed with the patient's primary care physician, [**Last Name (NamePattern4) **].
Prednisone taper:  [**1-17**], the patient is to receive 40 mg po q day of prednisone.
[**1-20**], the patient is to receive 20 mg po q day of prednisone.
Levofloxacin 500 mg po q day, [**1-17**] is day #7 of a 14 day course.
Cyanocobalamin 250 mcg po q day.
Lansoprazole 30 mg po q day.
Multivitamin one tablet po q day.
Albuterol two puffs po q6h.
Atrovent two puffs po qid.
Flovent 220 mcg,medial six puffs po bid.
Calcium carbonate 1,000 mg po bid.
Bupropion 150 mg po bid.
Albuterol nebulizer solution, one nebulizer po q2h prn wheezing (please note patient expressed desire to obtain a nebulizer for prn use at home).
While he does not require supplement oxygenation at rest on discharge from [**Hospital1 188**], he should have supplemental oxygen available via nasal cannula should he require it.
The patient should continue levofloxacin 500 mg po q day to complete a 14-day course as above.
Should have incentive spirometry, peak flow measurements, and pulmonary toilet.
Dr. [**Last Name (STitle) **] informs me that she may not have availability in her schedule, if this is the case, the patient can followup with Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **] at the same phone number.
